Trial Profile
A randomized, double-blind, placebo-controlled trial of ramosetron in patients with fibromyalgia.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Jun 2018
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 14 Jun 2018 New trial record